Clinically, reduced plasma HSP27 levels are strongly associated with T2DM-MCI, suggesting that it may serve as a sensitive biomarker for early detection of neurocognitive decline in diabetes (157). This evidence concerns the gene HSPB1 and type 2 diabetes mellitus.